Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhaoke Oncology is a biopharmaceutical company based in Guangzhou, China, and a subsidiary of Lee's Pharmaceutical Holdings. The company focuses on the development and commercialization of innovative oncology therapies, with a portfolio spanning immunotherapy, oncolytic viruses, and targeted small molecules. Its lead product, Socazolimab (an anti-PD-L1 antibody), received marketing approval in China for recurrent or metastatic cervical cancer. Zhaoke Oncology operates a state-of-the-art manufacturing facility in Nansha, Guangzhou, designed to meet international GMP standards. The company actively collaborates with international partners to bring advanced cancer treatments to the Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhaoke (Guangzhou) Oncology.